We were involved in the worldwide launch and product development of PEVIVA’s M30 Apoptosense ELISA -then distributed by ALEXIS Biochemicals, Switzerland back in 2000.
Since 2011 we act as PEVIVA’s (now VLVbio’s) apoptosis biomarker assay expert and distributor in the UK and the Republic of Ireland.
Through our long-standing unique assay insight and close collaboration with key opinion leaders, BIOAXXESS becomes your partner of choice for your biomarker project.
We serve customers in >50 UK hospitals and universities, but also R&D in pharma and biotech and through CROs for drug safety and mechanistic biomarker analysis in clinical trials.
PEVIVA‘s first-in-class CE-certified IVD cell death biomarker assays M30-Apoptosense® ELISA, M65® ELISA classic, and M65 EpiDeath® ELISA have been independently validated by pharmaceutical companies and clinical research centres for diagnostic use in oncology and hepatology.
PEVIVA is the original developer and manufacturer of the well-established M30-CytoDEATHTM Monoclonal Antibody directed against the caspase-cleaved neo-epitope M30 of Keratin-18 (K18Asp396-NE, ccK18, K18F-M30) and the only one to provide it in a convenient, stabilized stock solution with the widest range of conjugates for FACS, IHC and CTC analysis.
BIOAXXESS UK provides PEVIVA Cell Death Biomarker assays to Universities, Pharma, Biotech, CRO and Clinical Research and Diagnostic Laboratory Services.
If you have any questions, please get in touch via email: email@example.com.Visit PEVIVA Shop